Disgraced Pharma Bro Shkreli, post-prison, announces new ‘drug discovery software platform’

Disgraced Pharma Bro Shkreli, post-prison, announces new ‘drug discovery software platform’

In May, Martin Shkreli, the infamous “Pharma Bro,” was released from federal prison — and he will be living in a Federal Bureau of Prisons halfway house until September 14. Shkreli, post-prison, has announced a new business venture he’s calling Druglike.

In a press release dated Monday, July 25, Shkreli, now 39, described Druglike as a “Web3 drug discovery software platform," saying he launched the company because "traditional drug discovery software is too difficult and expensive to use."

The press release quotes Shkreli as saying, “For the first time, any computer or phone with access to the web might be responsible and rewarded for discovering the next breakthrough medicine. We will disrupt the economics of the drug business by allowing a wide pool of innovators and contributors, rather than only pharmaceutical giants, to profit from drug discovery."

READ MORE: 'Pharma Bro' Martin Shkreli ordered to return $64 million in profits gleaned from boosting price of life-saving drug

In the press release, Shkreli described Druglike as “a blockchain/Web3 software company,” stressing that it is “not a pharmaceutical company” and is "not engaged in pharmaceutical research or drug development."

In 2015, Shkreli drew widespread criticism for his price-gouging in the pharmaceutical industry. Thanks to Shkreli, the cost of the antiparasitic drug Daraprim went from $13.50 per pill to $750 per pill. Among health care reform activists, Shkreli became the symbol of everything that is dysfunctional about the health care and drug industries in the United States. And his critics labeled him “Pharma Bro.”

It wasn’t Shkreli’s price-gouging, however, that landed him in federal prison, but rather, being found guilty on two accounts of securities fraud. Shkreli, according to prosecutors, lied to investors about the performance of his hedge funds MSMB Capital and MSMB Healthcare — and in 2018, he was sentenced to seven years in federal prison. But he didn’t serve the entire seven years, and he was granted an early release for time served — that is, the six months he spent in custody before being sentenced — and for good behavior in prison.

READ MORE: Dems 'cannot overstate the paramount urgency' of passing bill after Big Pharma hikes prices on hundreds of drugs

Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ post.roar_specific_data.api_data.analytics }}
@2022 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by fontsempire.com.